NYSE:ZBHMedical Equipment
A Look At Zimmer Biomet (ZBH) Valuation After Strong Q1 2026 Results And CFO Transition
Why Zimmer Biomet’s latest earnings and leadership changes matter for investors
Zimmer Biomet Holdings (ZBH) has been in focus after Q1 2026 results showed higher sales and net income than a year earlier, alongside a CFO transition and reaffirmed full year revenue guidance.
For the quarter ended March 31, 2026, Zimmer Biomet reported sales of US$2,086.7 million compared with US$1,909.1 million in the same period last year. Net income was US$238.1 million versus US$182 million a year earlier,...